SCHEMBL42490

SCHEMBL42490

CC(C)NC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11752199 0.97
Ammonia Solution, Strong SCHEMBL29172696 0.97
Hydrochloric Acid SCHEMBL10822622 0.97
Ethylene SCHEMBL28794343 0.91 TSHR (0.46)
Isopropylamine SCHEMBL910714 0.91 ALDH1A1 (0.42)
Ethylenediamine SCHEMBL1929819 0.86 GABRR1 (0.42)
Ethylenediamine SCHEMBL1929817 0.86 GABRR1 (0.42)
Methanesulfonamide SCHEMBL4590913 0.84 CA1 (0.40)
SCHEMBL578763 0.80 MMP8 (0.39)
SCHEMBL7525656 0.79 CYP2D6 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1014 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118647379-A Methods and dosing regimens comprising a CDK2 inhibitor and a CDK4 inhibitor for treating cancer 辉瑞公司 2024-09-13 CN claimed
CN-113423711-B Thieno [3,2-B ] pyridine derivatives as UDP glycosyltransferase inhibitors and methods of use thereof 建新公司 2024-03-15 CN claimed
WO-2023233130-A1 CD73 INHIBITOR COMPOUNDS AdoRx Therapeutics Limited (GB) 2023-12-07 WO claimed
CN-116348455-A Protein tyrosine phosphatase inhibitors and methods of use thereof 卡里科生命科学有限责任公司 2023-06-27 CN claimed
WO-2023100134-A1 METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR AND A CDK4 INHIBITOR FOR TREATING CANCER PFIZER INC. (US) 2023-06-08 WO claimed
WO-2022270977-A1 NOVEL PYRIDINE DERIVATIVE COMPOUND AS RON INHIBITOR 주식회사 엘지화학 2022-12-29 WO claimed
CN-114502175-A Adenosine derivatives and pharmaceutical compositions containing the same 腾盛博药生物科技有限公司 2022-05-13 CN claimed
US-11326018-B2 Process for the synthesis of polyoxazolidinone compounds COVESTRO DEUTSCHLAND AG (DE) 2022-05-10 US claimed
US-11319398-B2 Method for the production of polyoxazolidinone polymer compounds COVESTRO DEUTSCHLAND AG (DE) 2022-05-03 US claimed
EP-3577149-B1 METHOD FOR THE PRODUCTION OF POLYOXAZOLIDINONE POLYMER COMPOUNDS COVESTRO INTELLECTUAL PROPERTY GMBH & CO KG (DE) 2022-02-09 EP claimed
EP-0547444-B1 Process for the preparation of high-purity aromatic di- and/or polyurethanes BAYER AG (DE) 1995-06-28 EP claimed
EP-0648771-A1 Galanthamine derivatives, a process for their preparation and their use as medicaments HOECHST-ROUSSEL PHARMACEUTICALS INCORPORATED (US) 1995-04-19 EP claimed
US-5238908-A HERBICIDAL GLUTARAMIC ACIDS AND DERIVATIVES ROHM AND HAAS COMPANY (US) 1993-08-24 US claimed
EP-0547444-A1 Process for the preparation of high-purity aromatic di- and/or polyurethanes BAYER AG (DE) 1993-06-23 EP claimed
WO-1991019715-A1 1H-SUBSTITUTED-IMIDAZO[4,5-d]PYRIDAZINE COMPOUNDS FOR TREATMENT OF CARDIOVASCULAR DISORDERS G.D. SEARLE & CO. (US) 1991-12-26 WO claimed
EP-0396709-A4 HUMAN LEUKOCYTE ELASTASE INHIBITORS AND METHODS OF PRODUCING AND USING SAME 1991-05-22 EP claimed
EP-0396709-A1 HUMAN LEUKOCYTE ELASTASE INHIBITORS AND METHODS OF PRODUCING AND USING SAME UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1990-11-14 EP claimed
EP-0367514-A2 Human leukocyte elastase inhibitors and methods for producing and using same UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 1990-05-09 EP claimed
EP-0072475-B1 CARBAMIC ESTERS, PREPARATION THEREOF, PESTICIDAL COMPOSITIONS ON THE BASIS OF THESE COMPOUNDS AND THEIR USE IN COMBATING PESTS F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1986-08-20 EP claimed
US-4130645-A Fungicidal phenylnitramines and new phenylnitramines AMERICAN CYANAMID COMPANY (US) 1978-12-19 US claimed